{"count": 27, "results": [{"_id": "39893002", "pmid": 39893002, "title": "Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer.", "journal": "J Pharmacol Exp Ther", "authors": ["Simpson K", "Allison DB", "He D", "Liu J", "Wang C", "Liu X"], "date": "2025-01-01T00:00:00Z", "doi": "10.1124/jpet.124.002424", "meta_date_publication": "2025 Jan", "meta_volume": "392", "meta_issue": "1", "meta_pages": "100034", "score": 50271.64, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in overcoming @CHEMICAL_enzalutamide @CHEMICAL_MESH:C540278 @@@enzalutamide@@@ resistance in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@castration-resistant prostate cancer@@@.", "citations": {"NLM": "Simpson K, Allison DB, He D, Liu J, Wang C, Liu X. Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer. J Pharmacol Exp Ther. 2025 Jan;392(1):100034. PMID: 39893002", "BibTeX": "@article{39893002, title={Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer.}, author={Simpson K and Allison DB and He D and Liu J and Wang C and Liu X}, journal={J Pharmacol Exp Ther}, volume={392}, number={1}, pages={100034}}"}}, {"_id": "36744171", "pmid": 36744171, "pmcid": "PMC9896090", "title": "A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer", "journal": "Clin Med Insights Oncol", "authors": ["Lee CS", "Lam SY", "Liu A", "Sison C", "Zhu XH"], "date": "2023-02-01T00:00:00Z", "doi": "10.1177/11795549231152073", "meta_date_publication": "2023", "meta_volume": "17", "meta_issue": "", "meta_pages": "11795549231152073", "score": 50267.19, "text_hl": "Within the @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@mCRPC@@@ group, the 6 month @GENE_KLK3 @GENE_354 @@@PSA@@@ response rates with and without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use were 38.5% and 57.1%, respectively (P < .238).", "citations": {"NLM": "Lee CS, Lam SY, Liu A, Sison C, Zhu XH. A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer Clin Med Insights Oncol. 2023;17():11795549231152073. PMID: 36744171", "BibTeX": "@article{36744171, title={A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer}, author={Lee CS and Lam SY and Liu A and Sison C and Zhu XH}, journal={Clin Med Insights Oncol}, volume={17}, pages={11795549231152073}}"}}, {"_id": "40216151", "pmid": 40216151, "title": "Metformin inhibits the progression of castration resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.", "journal": "Cancer Lett", "authors": ["Cai S", "Deng Y", "Zou Z", "Tian W", "Tang Z", "Li J", "Tan Z", "Wu Z", "Han Z", "Wen B", "Feng Y", "Liu R", "Zhu X", "Wu Y", "Xiao H", "He H", "Ye J", "Zhong W"], "date": "2025-04-09T00:00:00Z", "doi": "10.1016/j.canlet.2025.217694", "meta_date_publication": "2025 Apr 9", "meta_volume": "", "meta_issue": "", "meta_pages": "217694", "score": 50263.273, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has demonstrated a potential therapeutic effect on @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@. ", "citations": {"NLM": "Cai S, Deng Y, Zou Z, Tian W, Tang Z, Li J, Tan Z, Wu Z, Han Z, Wen B, Feng Y, Liu R, Zhu X, Wu Y, Xiao H, He H, Ye J, Zhong W. Metformin inhibits the progression of castration resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation. Cancer Lett. 2025 Apr 9;():217694. PMID: 40216151", "BibTeX": "@article{40216151, title={Metformin inhibits the progression of castration resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.}, author={Cai S and Deng Y and Zou Z and Tian W and Tang Z and Li J and Tan Z and Wu Z and Han Z and Wen B and Feng Y and Liu R and Zhu X and Wu Y and Xiao H and He H and Ye J and Zhong W}, journal={Cancer Lett}, pages={217694}}"}}, {"_id": "36478125", "pmid": 36478125, "title": "Mitochondrial respiration inhibitor enhances the anti-tumor effect of high-dose ascorbic acid in castration-resistant prostate cancer.", "journal": "J Mol Med (Berl)", "authors": ["Qiu J", "Yang T", "Long Y", "He P", "Shen W", "Zhang B", "Shi X", "Peng L", "Li Z", "Zhang X"], "date": "2022-12-07T00:00:00Z", "doi": "10.1007/s00109-022-02273-5", "meta_date_publication": "2022 Dec 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.31, "text_hl": "Taken together, our data demonstrate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ enhances the anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ proliferation effect of @CHEMICAL_Ascorbic_Acid @CHEMICAL_MESH:D001205 @@@ascorbic acid@@@ by increasing @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@ROS@@@ content in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@castration-resistant prostate cancer@@@. ", "citations": {"NLM": "Qiu J, Yang T, Long Y, He P, Shen W, Zhang B, Shi X, Peng L, Li Z, Zhang X. Mitochondrial respiration inhibitor enhances the anti-tumor effect of high-dose ascorbic acid in castration-resistant prostate cancer. J Mol Med (Berl). 2022 Dec 7;():. PMID: 36478125", "BibTeX": "@article{36478125, title={Mitochondrial respiration inhibitor enhances the anti-tumor effect of high-dose ascorbic acid in castration-resistant prostate cancer.}, author={Qiu J and Yang T and Long Y and He P and Shen W and Zhang B and Shi X and Peng L and Li Z and Zhang X}, journal={J Mol Med (Berl)}}"}}, {"_id": "34629300", "pmid": 34629300, "title": "TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.", "journal": "Clin Genitourin Cancer", "authors": ["Pujalte Martin M", "Borchiellini D", "Thamphya B", "Guillot A", "Paoli JB", "Besson D", "Hilgers W", "Priou F", "El Kouri C", "Hoch B", "Deville JL", "Schiappa R", "Cheli S", "Milano G", "Tanti JF", "Bost F", "Ferrero JM"], "date": "2021-12-01T00:00:00Z", "doi": "10.1016/j.clgc.2021.08.008", "meta_date_publication": "2021 Dec", "meta_volume": "19", "meta_issue": "6", "meta_pages": "501-509", "score": 50258.07, "text_hl": "We aimed at exploring the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ in combination with @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@DOCE@@@ in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@mCRPC@@@. ", "citations": {"NLM": "Pujalte Martin M, Borchiellini D, Thamphya B, Guillot A, Paoli JB, Besson D, Hilgers W, Priou F, El Kouri C, Hoch B, Deville JL, Schiappa R, Cheli S, Milano G, Tanti JF, Bost F, Ferrero JM. TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2021 Dec;19(6):501-509. PMID: 34629300", "BibTeX": "@article{34629300, title={TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.}, author={Pujalte Martin M and Borchiellini D and Thamphya B and Guillot A and Paoli JB and Besson D and Hilgers W and Priou F and El Kouri C and Hoch B and Deville JL and Schiappa R and Cheli S and Milano G and Tanti JF and Bost F and Ferrero JM}, journal={Clin Genitourin Cancer}, volume={19}, number={6}, pages={501-509}}"}}, {"_id": "34429755", "pmid": 34429755, "pmcid": "PMC8371978", "title": "Metformin mitigates PLCepsilon gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models", "journal": "Oncol Lett", "authors": ["Li Q", "Xu K", "Tian J", "Lu Z", "Pu J"], "date": "2021-10-01T00:00:00Z", "doi": "10.3892/ol.2021.12976", "meta_date_publication": "2021 Oct", "meta_volume": "22", "meta_issue": "4", "meta_pages": "715", "score": 50257.18, "text_hl": "...Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@ growth", "citations": {"NLM": "Li Q, Xu K, Tian J, Lu Z, Pu J. Metformin mitigates PLCepsilon gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models Oncol Lett. 2021 Oct;22(4):715. PMID: 34429755", "BibTeX": "@article{34429755, title={Metformin mitigates PLCepsilon gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models}, author={Li Q and Xu K and Tian J and Lu Z and Pu J}, journal={Oncol Lett}, volume={22}, number={4}, pages={715}}"}}, {"_id": "37189723", "pmid": 37189723, "pmcid": "PMC10135790", "title": "Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy", "journal": "Biomedicines", "authors": ["Congregado Ruiz B", "Rivero Belenchón I", "Lendínez Cano G", "Medina López RA"], "date": "2023-04-06T00:00:00Z", "doi": "10.3390/biomedicines11041105", "meta_date_publication": "2023 Apr 6", "meta_volume": "11", "meta_issue": "4", "meta_pages": "", "score": 50252.887, "text_hl": "@GENE_AR @GENE_367 @@@AR@@@-Dependent Mechanisms Triggering @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@", "citations": {"NLM": "Congregado Ruiz B, Rivero Belenchón I, Lendínez Cano G, Medina López RA. Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy Biomedicines. 2023 Apr 6;11(4):. PMID: 37189723", "BibTeX": "@article{37189723, title={Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy}, author={Congregado Ruiz B and Rivero Belenchón I and Lendínez Cano G and Medina López RA}, journal={Biomedicines}, volume={11}, number={4}}"}}, {"_id": "33024029", "pmid": 33024029, "title": "Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.", "journal": "Mol Cancer Ther", "authors": ["Kong Y", "Zhang Y", "Mao F", "Zhang Z", "Li Z", "Wang R", "Liu J", "Liu X"], "date": "2020-12-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-19-0874", "meta_date_publication": "2020 Dec", "meta_volume": "19", "meta_issue": "12", "meta_pages": "2490-2501", "score": 50251.664, "text_hl": "Collectively, our finding suggests that the combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_GSK_2816126 @CHEMICAL_MESH:C577920 @@@GSK126@@@ would be an effective approach for future @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ therapy, and particularly effective for @GENE_AR @GENE_367 @@@AR@@@-positive @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@castration-resistant prostate cancer@@@.", "citations": {"NLM": "Kong Y, Zhang Y, Mao F, Zhang Z, Li Z, Wang R, Liu J, Liu X. Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer. Mol Cancer Ther. 2020 Dec;19(12):2490-2501. PMID: 33024029", "BibTeX": "@article{33024029, title={Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.}, author={Kong Y and Zhang Y and Mao F and Zhang Z and Li Z and Wang R and Liu J and Liu X}, journal={Mol Cancer Ther}, volume={19}, number={12}, pages={2490-2501}}"}}, {"_id": "25122066", "pmid": 25122066, "title": "Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.", "journal": "Mol Cancer Ther", "authors": ["Babcook MA", "Shukla S", "Fu P", "Vazquez EJ", "Puchowicz MA", "Molter JP", "Oak CZ", "MacLennan GT", "Flask CA", "Lindner DJ", "Parker Y", "Daneshgari F", "Gupta S"], "date": "2014-10-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-14-0451", "meta_date_publication": "2014 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "2288-302", "score": 50065.56, "text_hl": "Synergistic @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination chemotherapy for osseous metastatic @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@castration-resistant prostate cancer@@@.", "citations": {"NLM": "Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2288-302. PMID: 25122066", "BibTeX": "@article{25122066, title={Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.}, author={Babcook MA and Shukla S and Fu P and Vazquez EJ and Puchowicz MA and Molter JP and Oak CZ and MacLennan GT and Flask CA and Lindner DJ and Parker Y and Daneshgari F and Gupta S}, journal={Mol Cancer Ther}, volume={13}, number={10}, pages={2288-302}}"}}, {"_id": "23287698", "pmid": 23287698, "title": "Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.", "journal": "Eur Urol", "authors": ["Spratt DE", "Zhang C", "Zumsteg ZS", "Pei X", "Zhang Z", "Zelefsky MJ"], "date": "2013-04-01T00:00:00Z", "doi": "10.1016/j.eururo.2012.12.004", "meta_date_publication": "2013 Apr", "meta_volume": "63", "meta_issue": "4", "meta_pages": "709-16", "score": 50063.293, "text_hl": "OBJECTIVE: To determine whether the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ would be associated with improved clinical outcomes and a reduction in the development of @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@. ", "citations": {"NLM": "Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol. 2013 Apr;63(4):709-16. PMID: 23287698", "BibTeX": "@article{23287698, title={Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.}, author={Spratt DE and Zhang C and Zumsteg ZS and Pei X and Zhang Z and Zelefsky MJ}, journal={Eur Urol}, volume={63}, number={4}, pages={709-16}}"}}]}